New drug DSB2455 targets Hard-to-Treat cancers in early trial
Disease control
Recruiting now
This early-phase study tests a new drug called DSB2455 in adults with advanced cancers (breast, ovarian, prostate, pancreatic, or brain metastases) that have a specific DNA repair problem. The main goals are to check safety and see if the drug shrinks tumors. About 180 participan…
Phase: PHASE1 • Sponsor: Duke Street Bio Ltd • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC